Nemaura Medical Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2014 - 2018
Period Ending	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	2014 - 2018
Revenue	0.08	0.5	-	-	-	Upgrade
Revenue Growth (YoY)	-84.71%	-	-	-	-	Upgrade
Cost of Revenue	1.55	0.34	-	-	-	Upgrade
Gross Profit	-1.48	0.16	-	-	-	Upgrade
Selling, General & Admin	5.6	6.17	3.03	2.77	2.18	Upgrade
Research & Development	1.54	1.56	1.55	2.01	2.3	Upgrade
Operating Expenses	7.14	7.73	4.59	4.78	4.48	Upgrade
Operating Income	-8.62	-7.57	-4.59	-4.78	-4.48	Upgrade
Interest Expense	-6.41	-6.67	-2.01	-	-	Upgrade
Interest & Investment Income	-	-	-	0	0.02	Upgrade
Other Non Operating Income (Expenses)	1.86	-	-	-	-	Upgrade
EBT Excluding Unusual Items	-13.16	-14.24	-6.59	-4.77	-4.45	Upgrade
Asset Writedown	-0.98	-	-	-	-	Upgrade
Pretax Income	-14.14	-14.24	-6.59	-4.77	-4.45	Upgrade
Income Tax Expense	-	-0.35	-0.34	-0.61	-	Upgrade
Net Income	-14.14	-13.89	-6.26	-4.16	-4.45	Upgrade
Net Income to Common	-14.14	-13.89	-6.26	-4.16	-4.45	Upgrade
Shares Outstanding (Basic)	25	23	22	21	18	Upgrade
Shares Outstanding (Diluted)	25	23	22	21	18	Upgrade
Shares Change (YoY)	6.39%	4.94%	7.10%	15.01%	20.55%	Upgrade
EPS (Basic)	-0.57	-0.59	-0.28	-0.20	-0.25	Upgrade
EPS (Diluted)	-0.57	-0.59	-0.28	-0.20	-0.25	Upgrade
Free Cash Flow	-8.83	-6.99	-6.09	-3.61	-3.62	Upgrade
Free Cash Flow Per Share	-0.35	-0.30	-0.27	-0.17	-0.20	Upgrade
Gross Margin	-	31.67%	-	-	-	Upgrade
Operating Margin	-11182.17%	-1502.35%	-	-	-	Upgrade
Profit Margin	-18358.00%	-2755.83%	-	-	-	Upgrade
Free Cash Flow Margin	-11458.32%	-1386.32%	-	-	-	Upgrade
EBITDA	-8.17	-7.34	-4.49	-4.72	-4.44	Upgrade
D&A For EBITDA	0.44	0.23	0.1	0.05	0.03	Upgrade
EBIT	-8.62	-7.57	-4.59	-4.78	-4.48	Upgrade

Updated Feb 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.